DIEP皮瓣与荧光血管造影:一项随机对照临床试验
该平行随机对照试验纳入51例单侧乳房再造患者,比较基于临床评估(组1)与基于吲哚菁绿荧光血管造影标准(组2)切除DIEP皮瓣血运不良组织的效果。组2灌注率更高(p=0.001),脂肪坏死发生率组1为59.3%、组2为8.3%(p=0.001),且组2的BREAST-Q各领域评分更高。结论认为吲哚菁绿荧光血管造影可安全有效减少脂肪坏死且不缩小皮瓣尺寸。
要点
- 吲哚菁绿荧光血管造影可显著降低DIEP皮瓣脂肪坏死发生率(8.3% vs 59.3%,p=0.001)。
- 造影组皮瓣灌注率更高(p=0.001),且不缩小皮瓣尺寸。
- 造影组BREAST-Q各领域评分更高,患者满意度与生活质量更优。
核心结论
- 吲哚菁绿荧光血管造影可显著降低DIEP皮瓣脂肪坏死发生率且不缩小皮瓣尺寸。
- 造影组灌注率显著更高,患者满意度和生活质量显著更优。
- 吲哚菁绿荧光血管造影可视为提升DIEP皮瓣乳房再造结局的安全有效工具。
研究设计与样本
- 平行随机对照临床试验,纳入51例单侧乳房再造患者。
- 组1基于临床评估切除DIEP皮瓣血运不良组织,组2基于血管造影标准切除。
- 记录皮瓣尺寸、荧光强度灌注、并发症、再手术及BREAST-Q问卷评分。
主要发现
- 组织切除后两组皮瓣尺寸无差异。
- 组2灌注率更高(p=0.001)。
- 脂肪坏死发生率组1为59.3%、组2为8.3%(p=0.001)。
- 组1部分坏死4例(18.2%),组2无(0%)(p=0.131)。
- 组1再手术4例(14.8%),组2无(0%)(p=0.113)。
关键数值与推荐
- 脂肪坏死发生率组1为59.3%、组2为8.3%(p=0.001)。
- 部分坏死率组1为18.2%、组2为0%(p=0.131)。
- 再手术率组1为14.8%、组2为0%(p=0.113)。
- 组2灌注率更高(p=0.001)。
临床怎么用
- DIEP皮瓣乳房再造中可考虑使用吲哚菁绿荧光血管造影评估灌注以指导组织切除。
- 依据造影标准切除血运不良组织可能降低脂肪坏死发生率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast reconstruction with the deep inferior epigastric perforator (DIEP) flap can be associated with complications such as fat necrosis. The authors' objective was to assess the safety and efficacy of fluorescent angiography with indocyanine green to reduce fat necrosis. METHODS: The authors designed a parallel, randomized, controlled clinical trial for unilateral breast reconstruction. The poorly vascularized tissues of the DIEP flap were removed based on a clinical evaluation in group 1 and based on angiographic criteria in group 2. The authors recorded the flap dimensions, perfusion in terms of fluorescence intensity, complications, reoperations, and BREAST-Q questionnaire scores for both groups. RESULTS: The study included a total of 51 patients. The flaps showed no size differences after the tissue was excised. The flaps of group 2 presented higher perfusion rates (p = 0.001). The incidence of fat necrosis was 59.3 percent in group 1 and 8.3 percent in group 2 (p = 0.001). Four cases of partial necrosis were recorded in group 1 (18.2 percent) compared with none in group 2 (0 percent) (p = 0.131). Four patients underwent reoperation in group 1 (14.8 percent) compared with none in group 2 (0 percent) (p = 0.113). The patients in group 2 reported higher scores in all domains of the BREAST-Q. CONCLUSIONS: Fluorescent angiography with indocyanine green significantly reduced the incidence of fat necrosis without diminishing the flaps' dimensions. The perfusion rates were significantly higher and the patients reported significantly greater satisfaction and quality of life. Fluorescent angiography with indocyanine green may be considered a safe and effective tool to enhance the outcomes of breast reconstruction with the DIEP flap. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, I.
引用
- Varela R, Casado-Sanchez C, Zarbakhsh S, et al. Outcomes of DIEP Flap and Fluorescent Angiography: A Randomized Controlled Clinical Trial. Plast Reconstr Surg. 2020. PMID: 31577664. doi:10.1097/PRS.0000000000006393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。